KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares RepurchasedWages, Salaries and Other
Ratios

Globus Medical (GMED) Cost of Revenue (2016 - 2026)

Globus Medical filings provide 15 years of Cost of Revenue readings, the most recent being $261.1 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue fell 0.88% to $261.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $957.8 million, a 7.5% decrease, with the full-year FY2025 number at $957.8 million, down 7.5% from a year prior.
  • Cost of Revenue hit $261.1 million in Q4 2025 for Globus Medical, up from $252.5 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $270.5 million in Q3 2024 to a low of $55.0 million in Q1 2021.
  • Median Cost of Revenue over the past 5 years was $105.9 million (2023), compared with a mean of $152.2 million.
  • Biggest five-year swings in Cost of Revenue: surged 276.09% in 2023 and later dropped 19.09% in 2025.
  • Globus Medical's Cost of Revenue stood at $61.8 million in 2021, then increased by 14.23% to $70.6 million in 2022, then surged by 276.09% to $265.5 million in 2023, then dropped by 0.77% to $263.4 million in 2024, then dropped by 0.88% to $261.1 million in 2025.
  • The last three reported values for Cost of Revenue were $261.1 million (Q4 2025), $252.5 million (Q3 2025), and $248.8 million (Q2 2025) per Business Quant data.